Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-06

Clinical Trial Update: A Study to Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating zonisamide as add-on therapy for elderly patients with refractory partial seizures; the study was terminated with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonisamide (zonisamide)

Snippet

Sponsor: Eisai Limited | Conditions: Epilepsy | Phase 4 | Status: TERMINATED | Results posted: 2013-02-06